Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Barbara White Insider Profile
11 Followers
Barbara White, CMO at Corbus Pharmaceuticals, holds 118.56K shares in Corbus Pharmaceuticals (Ticker: CRBP). Most recently, Barbara White Bought $15,606 shares of Corbus Pharmaceuticals on Mar 18, 2020 for an estimated value of 56.65K.
Profitable Transactions
12 out of 28 Profitable Transactions
Average Return
+32.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
CMO
Roles that Barbara White holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Nov 23, 2015 - Nov 23, 2016
Return:+357.10%
The most profitable trade made by Barbara White
Barbara White's Trading History
List of latest transactions for each holding click on a transaction to see Barbara White's performance on stock
You May Also Like
Barbara White insider profile FAQ
What is the percentage of profitable transactions made by Barbara White?
The percentage of profitable transactions made by Barbara White is 43%.
What is the average return per transaction made by Barbara White?
The average return per transaction made by Barbara White is 32.40%.
What stocks does Barbara White hold?
Barbara White holds: CRBP stocks.
What was Barbara White’s latest transaction?
Barbara White latest transaction was an Informative Buy of $56.65K.
What was Barbara White's most profitable transaction?
Barbara White’s most profitable transaction was an Informative Buy of CRBP stock on November 23, 2015. The return on the trade was 357.10%.
What is Barbara White's role in Corbus Pharmaceuticals?
Barbara White's role in Corbus Pharmaceuticals is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.